Pioneers in Women's Health
The Viramal team
Our team is led by pioneers in the women's health sector who have developed and licensed market-leading products in the fields of fertility and sexual health.
The senior management team is an experienced cohort with a successful track-record in developing and commercialising innovative therapies for biotechnology companies across the US, Europe and Scandinavia.
Our Board comprises veterans and leading advisors from Industry and the FemMedTech sector.
Management Team
and Executive
Board Members
Oliver Bates
Chief executive officer and co-founder
More info- Experienced biotech & pharma executive
- Private equity and corporate finance background with emerging and entrepreneurial pharmaceutical and technology businesses
- Broad transaction experience
Dr Simona Fiore
Chief medical officer
More info- Board Certified OBGYN obtaining a PhD whilst a Medical Research Council Fellow
- Scientific Coordinator for the ESHRE Task Force
- An experienced physician, with experience of running European studies for the NIH across Europe.
Peter Fitzwilliam
Chief financial officer
More info- Experienced FTSE 250 public company Finance Director working both in the UK and USA
- Group Finance Director for AIM listed Mission Marketing Group plc.
- Chartered Accountant
Non Executive
Board Members
GP Singh
Non Executive Director
More info- Experienced global pharma CEO.
- Previous CEO Jubilant Pharma, US President Sun Pharma.
Dr Finn Larsen
Chairman of Science and Portfolio Development
More info- Seasoned pharma exec in various Clinical Development leadership roles for European and US Bio-Pharma companies including Ardana Plc (Edinburgh), Columbia Laboratories (Paris), and Ipsen (London).
Nick Thorniley
Non Executive Director
More info- Public company bio-tech chairman, having had a long and well-respected career in the City of London in corporate broking with small to mid-capitalised companies.
Jonathan Synett
Investment Director
More info- Experienced Fund Manager, and Board Representative for the DPTI Fund where he is the Fund Manager.
Claus Frøkjær-Lorendsen
Investment Board Observer
More info- CEO of Copenhagen-based METIS Family Office A/S, representing Investeringsselskabet MFO Private Equity A/S investment on the Viramal Board.
Denise Lewis Poulton
Senior Communications Advisor
More info- Launched the Orange brand in 22 countries, and its IPO (largest in Europe)
- As Group Director of Corporate Affairs, oversaw the merger of 4 cable companies forming Cable and Wireless PLC, including its IPO on NASDAQ.